2009Journal of GastroenterologyRequires access

Lamivudine-to-entecavir switching treatment in type B chronic hepatitis patients without evidence of lamivudine resistance

Nao Kurashige, Kazuyoshi Ohkawa, Naoki Hiramatsu, Takayuki Yakushijin, Kiyoshi Mochizuki, Tsugiko Oze, Shinichi Kiso, Tatsuya Kanto, Tetsuo Takehara, Akinori Kasahara, Yoshinori Doi, Akira Yamada, Kazuto Fukuda, Masahide Oshita, Eiji Mita, Hiroyuki Fukui, Toshihiko Nagase, Harumasa Yoshihara, Yasuharu Imai, Michio Kato, Takeshi Kashihara, Norio Hayashi

Open publisher page 13 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 13 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Lamivudine, Entecavir, Medicine, Virology, Hepatitis B virus, Chronic hepatitis, Hepatitis B, Gastroenterology

Related papers

Back to paper searchBrowse research topicsOriginal source
Lamivudine-to-entecavir switching treatment in type B chronic hepatitis patients without evidence of lamivudine resistance — Research Paper | ScholarLens